calcitriol indications/contra

Stem definitionDrug idCAS RN
Vitamin D analogues/derivatives 466 32222-06-3

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • rocaltrol
  • calcitriol
  • Dihydroxyvitamin D3
  • topitriol
  • 1,25-dihydroxyvitamin D3
The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption.
  • Molecular weight: 416.65
  • Formula: C27H44O3
  • CLOGP: 6.04
  • LIPINSKI: 1
  • HAC: 3
  • HDO: 3
  • TPSA: 60.69
  • ALOGS: -4.80
  • ROTB: 6

Drug dosage:

DoseUnitRoute
1 mcg O
1 mcg P

Approvals:

DateAgencyCompanyOrphan
Aug. 17, 1978 FDA VALIDUS PHARMS

FDA Adverse Event Reporting System

scroll-->
MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Hypercalcaemia 851.77 32.92 134 455 3603 3381667
Milk-alkali syndrome 141.72 32.92 19 570 139 3385131
Hospitalisation 138.70 32.92 41 548 20684 3364586
Nephrocalcinosis 122.72 32.92 18 571 266 3385004
Arteriovenous fistula site complication 121.75 32.92 17 572 173 3385097
Acute kidney injury 114.26 32.92 44 545 49639 3335631
Calciphylaxis 76.72 32.92 13 576 498 3384772
Blood creatinine increased 63.23 32.92 23 566 21795 3363475
Hypocalcaemia 58.99 32.92 16 573 5805 3379465
Blood parathyroid hormone increased 57.57 32.92 11 578 831 3384439
Metabolic alkalosis 56.85 32.92 10 579 477 3384793
Polyuria 48.19 32.92 11 578 1970 3383300
Transplant rejection 47.50 32.92 11 578 2100 3383170
Vomiting 47.18 32.92 29 560 89502 3295768
Decreased appetite 45.86 32.92 22 567 41468 3343802
Hypertension 44.34 32.92 21 568 38445 3346825
Abdominal pain 43.60 32.92 22 567 46203 3339067
Renal impairment 41.01 32.92 16 573 18245 3367025
Hyperparathyroidism 35.45 32.92 7 582 626 3384644
Nausea 35.25 32.92 28 561 129617 3255653
Renal failure 34.93 32.92 17 572 32923 3352347
Cardiovascular disorder 34.24 32.92 10 579 4713 3380557
Acute myeloid leukaemia 33.34 32.92 10 579 5163 3380107

Pharmacologic Action:

scroll-->
SourceCodeDescription
ATC A11CC04 ALIMENTARY TRACT AND METABOLISM
VITAMINS
VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO
Vitamin D and analogues
ATC D05AX03 DERMATOLOGICALS
ANTIPSORIATICS
ANTIPSORIATICS FOR TOPICAL USE
Other antipsoriatics for topical use
FDA Chemical/Ingredient N0000006996 Cholecalciferol
FDA EPC N0000175908 Vitamin D3 Analog
MeSH PA D050071 Bone Density Conservation Agents
MeSH PA D002120 Calcium Channel Agonists
MeSH PA D002317 Cardiovascular Agents
MeSH PA D006133 Growth Substances
MeSH PA D049990 Membrane Transport Modulators
MeSH PA D018977 Micronutrients
MeSH PA D014662 Vasoconstrictor Agents
MeSH PA D014815 Vitamins
CHEBI has role CHEBI:50733 nutraceutical
CHEBI has role CHEBI:50748 antipsoriatic
CHEBI has role CHEBI:50846 immunomodulator
CHEBI has role CHEBI:35610 antineoplastic agent
CHEBI has role CHEBI:50646 bone density conservation agent

Drug Use (View source of the data)

scroll-->
DiseaseRelationSNOMED_IDDOID
Hypophosphatemia indication 4996001
Hypocalcemia indication 5291005
Renal osteodystrophy indication 16726004 DOID:13068
Hypoparathyroidism indication 36976004 DOID:11199
Plaque psoriasis indication 200965009
Hyperparathyroidism Secondary to Chronic Renal Failure indication
Hypocalcemia from End-Stage Renal Disease with Dialysis indication
Hyperphosphatemia contraindication 20165001 DOID:0050459
Hypervitaminosis D contraindication 27712000 DOID:9971
Sarcoidosis contraindication 31541009 DOID:13404
Hypercalcemia contraindication 66931009 DOID:12678
Kidney disease contraindication 90708001 DOID:2527
Kidney stone contraindication 95570007
Arteriosclerosis obliterans contraindication 361133006 DOID:5160
Hypercalcemia associated with Sarcoidosis contraindication
Neonatal hypocalcemic tetany off-label use 18442000
Vitamin D deficiency off-label use 34713006
Rickets off-label use 41345002 DOID:10609
Familial x-linked hypophosphatemic vitamin D refractory rickets off-label use 82236004
Vitamin D Dependent Rickets off-label use

Acid dissociation constants calculated using MoKa v3.0.0

scroll-->
Dissociation levelDissociation constantType (acidic/basic)
pKa1 13.7 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

scroll-->
TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Vitamin D3 receptor Nuclear hormone receptor AGONIST EC50 8.40 WOMBAT-PK CHEMBL
Vitamin D 25-hydroxylase Enzyme WOMBAT-PK
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial Enzyme WOMBAT-PK
Vitamin D-binding protein Secreted Kd 7.62 CHEMBL
Vitamin D3 receptor Transcription factor EC50 10.30 CHEMBL
Vitamin D3 receptor Unclassified Kd 10.15 CHEMBL
Vitamin D3 receptor Transcription factor Ki 10.30 CHEMBL
Vitamin D3 receptor Transcription factor Ki 10.60 CHEMBL
Vitamin D3 receptor A Nuclear hormone receptor EC50 8.26 CHEMBL

External reference:

scroll-->
IDSource
DB00136 DRUGBANK_ID
4017800 VUID
N0000146161 NUI
C0006674 UMLSCUI
2779 IUPHAR_LIGAND_ID
D00129 KEGG_DRUG
CHEMBL846 ChEMBL_ID
4017800 VANDF
N0000006511 NDFRT
N0000146161 NDFRT
001017 NDDF
42410 MMSL
1894 RXNORM
259333003 SNOMEDCT_US
4324 MMSL
d03126 MMSL
68206008 SNOMEDCT_US
5280453 PUBCHEM_CID
D002117 MESH_DESCRIPTOR_UI
FXC9231JVH UNII
4393 INN_ID
CHEBI:17823 CHEBI
VDX PDB_CHEM_ID

Pharmaceutical products:

scroll-->
ProductCategoryIngredientsNDCFormQuantityRoute MarketingLabel
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 0054-0007 CAPSULE 0.25 ug ORAL ANDA 17 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 0054-3120 SOLUTION 1 ug ORAL ANDA 14 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 0093-7352 CAPSULE, LIQUID FILLED 0.25 ug ORAL ANDA 13 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 0093-7353 CAPSULE, LIQUID FILLED 0.50 ug ORAL ANDA 13 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 0143-9728 INJECTION 1 ug INTRAVENOUS ANDA 12 sections
Rocaltrol HUMAN PRESCRIPTION DRUG LABEL 1 0179-0063 CAPSULE, GELATIN COATED 0.50 ug ORAL NDA 12 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 0179-0196 CAPSULE, LIQUID FILLED 0.25 ug ORAL ANDA 11 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 0179-0197 CAPSULE, LIQUID FILLED 0.50 ug ORAL ANDA 11 sections
Vectical HUMAN PRESCRIPTION DRUG LABEL 1 0299-2012 OINTMENT 3 ug TOPICAL NDA 16 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 17478-831 INJECTION 1 ug INTRAVENOUS ANDA 12 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 17478-931 INJECTION 1 ug INTRAVENOUS ANDA 12 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 17478-932 INJECTION 2 ug INTRAVENOUS ANDA 12 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 17856-0723 CAPSULE 0.25 ug ORAL ANDA 13 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 23155-118 CAPSULE, LIQUID FILLED 0.25 ug ORAL ANDA 11 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 23155-119 CAPSULE, LIQUID FILLED 0.50 ug ORAL ANDA 11 sections
Rocaltrol HUMAN PRESCRIPTION DRUG LABEL 1 30698-911 SOLUTION 1 ug ORAL NDA 12 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 43353-034 CAPSULE 0.25 ug ORAL ANDA 18 sections
CALCITRIOL HUMAN PRESCRIPTION DRUG LABEL 1 43353-138 CAPSULE 0.25 ug ORAL NDA authorized generic 13 sections
Rocaltrol HUMAN PRESCRIPTION DRUG LABEL 1 43353-633 CAPSULE, GELATIN COATED 0.25 ug ORAL NDA 13 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 43353-998 CAPSULE, LIQUID FILLED 0.25 ug ORAL ANDA 12 sections
calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 45802-608 OINTMENT 3 ug TOPICAL NDA 17 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 54868-4582 CAPSULE, LIQUID FILLED 0.50 ug ORAL ANDA 12 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 54868-4584 CAPSULE, LIQUID FILLED 0.25 ug ORAL ANDA 12 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 54868-6265 INJECTION, SOLUTION 1 mg INTRAVENOUS ANDA 12 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 55154-4847 CAPSULE, LIQUID FILLED 0.25 ug ORAL ANDA 13 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 55154-8251 CAPSULE, LIQUID FILLED 0.25 ug ORAL ANDA 13 sections
Calcitriol HUMAN PRESCRIPTION DRUG LABEL 1 55154-8281 CAPSULE, LIQUID FILLED 0.50 ug ORAL ANDA 13 sections
CALCITRIOL HUMAN PRESCRIPTION DRUG LABEL 1 63304-239 CAPSULE 0.25 ug ORAL NDA authorized generic 12 sections
CALCITRIOL HUMAN PRESCRIPTION DRUG LABEL 1 63304-240 CAPSULE 0.50 ug ORAL NDA authorized generic 12 sections
CALCITRIOL HUMAN PRESCRIPTION DRUG LABEL 1 63304-241 SOLUTION 1 ug ORAL NDA authorized generic 12 sections